R. Moog et al., Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC-reduced RBC apheresis concentrates, TRANSFUSION, 41(9), 2001, pp. 1159-1164
BACKGROUND: Multicomponent apheresis procedures offer the possibility of co
llecting blood components that are standardized, as compared to those avail
able with whole-blood donations. A new separator program for the concurrent
collection of RBCs, platelets, and plasma (Amicus, Baxter Healthcare) was
evaluated.
STUDY DESIGN AND METHODS: Apheresis donors (n = 47) underwent concurrent co
llection of RBCs, platelets, and plasma by use of the single-needle procedu
re of the Amicus blood cell separator. A standardized RBC volume (100% Hct)
of 200 mL was targeted with either 1 or 2 platelet concentrate units, depe
nding on the donor's predonation characteristics. After collection, the RBC
component was sterilely connected to an RBC collection set (Amicus) to all
ow for the addition of 100 mL of saline-adenine-glucose-mannitol preservati
ve solution and WBC reduction at either ambient temperature or 4 degreesC.
The RBC units were subsequently stored at 2 to 6 degreesC for 42 days, and
the following in vitro measures were evaluated over the storage period: blo
od cell counts including Hct and total Hb, plasma Hb, potassium, pH, ATP, a
nd 2,3 DPG.
RESULTS: Procedure time averaged 74 +/- 9 minutes, and no adverse events we
re reported. The absolute RBC volume collected averaged 198 +/- 11 mL with
an average Hct value of 83 +/- 2 percent. After filtration, the Hb content
averaged 58.2 +/- 2.4 g per unit and residual WBCs averaged 0.038 +/- 0.015
x 10(6) per unit. Day 42 results showed that all units had on average more
than 70-percent ATP maintenance, and all of the units had less than 0.8 pe
rcent hemolysis. All units had pH values higher than 6.5 on Day 42.
CONCLUSION: The concurrent multicomponent collection system (Amicus) can re
liably collect a standardized RBC unit of good quality. In vitro testing of
the RBCs collected and stored for 42 days met the Council of Europe criter
ia for transfusion.